Short interfering RNA (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Short interfering RNA" in Italian language version.

refsWebsite

Global rank Italian rank

4^th place

9^th place

2^nd place

7^th place

234^th place

226^th place

6^th place

8^th place

1biochemsoctrans.org

low place

low place

222^nd place

243^rd place

799^th place

22^nd place

archive.org

Li LC, Small RNA-Mediated Gene Activation. RNA and the Regulation of Gene Expression: A Hidden Layer of Complexity, Caister Academic Press, 2008, ISBN 978-1-904455-25-7.

biochemsoctrans.org

(EN) Sledz CA et al RNA interference and double-stranded-RNA-activated pathways. Biochem. Soc. Trans.. (2004) 32, (952–956)

doi.org

dx.doi.org

H Shen, T Sun e M Ferrari, Nanovector delivery of siRNA for cancer therapy, in Cancer Gene Therapy, vol. 19, n. 6, pp. 367–373, DOI:10.1038/cgt.2012.22.
John C. Burnett e John J. Rossi, RNA-Based Therapeutics: Current Progress and Future Prospects, in Chemistry & Biology, vol. 19, n. 1, 27 gennaio 2012, pp. 60–71, DOI:10.1016/j.chembiol.2011.12.008. URL consultato l'11 luglio 2016.
Josep Tabernero, Geoffrey I. Shapiro e Patricia M. LoRusso, First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement, in Cancer Discovery, vol. 3, n. 4, 1º aprile 2013, pp. 406–417, DOI:10.1158/2159-8290.CD-12-0429. URL consultato l'11 luglio 2016.
Thomas W. Geisbert, Amy C. H. Lee e Marjorie Robbins, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study, in Lancet (London, England), vol. 375, n. 9729, 29 maggio 2010, pp. 1896–1905, DOI:10.1016/S0140-6736(10)60357-1. URL consultato l'11 luglio 2016.

nature.com

(EN) Kim DH et al Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nature Biotechnology 23, 222 - 226 (2004)
(EN) Birmingham A et al 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets Nature Methods 3, 199 - 204 (2006)
H Shen, T Sun e M Ferrari, Nanovector delivery of siRNA for cancer therapy, in Cancer Gene Therapy, vol. 19, n. 6, pp. 367–373, DOI:10.1038/cgt.2012.22.

nih.gov

ncbi.nlm.nih.gov

(EN) Hamilton AJ, Baulcombe DC, A species of small antisense RNA in posttranscriptional gene silencing in plants, Science. 1999 Oct 29;286(5441):950-2
(EN) Elbashir SM et al, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature. 2001 May 24;411(6836):494-8
(EN) Emily Bernstein et al, Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature 409, 363-366 (18 January 2001)
Josep Tabernero, Geoffrey I. Shapiro e Patricia M. LoRusso, First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement, in Cancer Discovery, vol. 3, n. 4, 1º aprile 2013, pp. 406–417, DOI:10.1158/2159-8290.CD-12-0429. URL consultato l'11 luglio 2016.
Thomas W. Geisbert, Amy C. H. Lee e Marjorie Robbins, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study, in Lancet (London, England), vol. 375, n. 9729, 29 maggio 2010, pp. 1896–1905, DOI:10.1016/S0140-6736(10)60357-1. URL consultato l'11 luglio 2016.

oadoi.org

John C. Burnett e John J. Rossi, RNA-Based Therapeutics: Current Progress and Future Prospects, in Chemistry & Biology, vol. 19, n. 1, 27 gennaio 2012, pp. 60–71, DOI:10.1016/j.chembiol.2011.12.008. URL consultato l'11 luglio 2016.

wiley.com

www3.interscience.wiley.com

(EN) Zhang Z et al siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J Cell Biochem. 2006 Apr 15;97(6):1217-29